NewAmsterdam Pharma Ownership | Who Owns NewAmsterdam Pharma?


OverviewForecastRevenueFinancialsChart

NewAmsterdam Pharma Ownership Summary


NewAmsterdam Pharma is owned by 103.38% institutional investors, 0.39% insiders. Frazier life sciences management is the largest institutional shareholder, holding 14.76% of NAMS shares. American Funds SMALLCAP World A is the top mutual fund, with 7.48% of its assets in NewAmsterdam Pharma shares.

NAMS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNewAmsterdam Pharma103.38%0.39%-3.76%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Frazier life sciences management16.61M14.76%$300.75M
Bain capital life sciences investors10.72M9.53%$194.12M
Fcpm iii services b.v.10.63M9.45%$192.55M
Ra capital management10.14M9.01%$183.62M
Capital world investors8.39M7.46%$151.90M
Viking global investors lp6.98M6.20%$126.38M
Deerfield management company, l.p. (series c)5.12M4.55%$92.65M
Adage capital partners gp3.01M2.68%$54.57M
Jennison associates2.95M2.62%$53.35M
Medicxi ventures management (jersey)2.87M2.55%$51.97M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Fcpm iii services b.v.10.63M52.16%$192.55M
Bain capital life sciences investors10.72M24.29%$194.12M
Medicxi ventures management (jersey)2.87M12.16%$51.97M
Frazier life sciences management16.61M12.03%$300.75M
Decheng capital770.00K3.52%$13.94M
Ra capital management10.14M3.09%$183.62M
Cormorant asset management, lp2.17M2.93%$39.39M
Deerfield management company, l.p. (series c)5.12M1.68%$92.65M
Saturn v capital management220.69K1.62%$4.00M
Healthinvest partners ab157.22K1.22%$2.85M

Top Buyers

HolderShares% AssetsChange
Capital world investors8.39M0.02%1.59M
Adage capital partners gp3.01M0.09%1.06M
Deerfield management company, l.p. (series c)5.12M1.68%1.01M
Maverick capital1.53M0.42%982.40K
Frazier life sciences management16.61M12.03%490.66K

Top Sellers

HolderShares% AssetsChange
Jennison associates2.95M0.03%-1.02M
Siren1.19M1.12%-717.79K
Cormorant asset management, lp2.17M2.93%-650.00K
Opaleye management---325.00K
Fcpm iii services b.v.10.63M52.16%-303.20K

New Positions

HolderShares% AssetsChangeValue
Ikarian capital206.80K0.72%206.80K$3.75M
Handelsbanken fonder ab187.40K0.02%187.40K$4.82M
Nicholas investment partners, lp115.74K0.19%115.74K$2.10M
Adar1 capital management112.36K0.31%112.36K$2.03M
China universal asset management19.59K0.05%19.59K$503.44K

Sold Out

HolderChange
Gamma investing-7.00
Principal securities-13.00
Coldstream capital management-24.00
Global retirement partners-91.00
Assetmark-96.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20251353.05%116,309,19516.74%1031.40%8511.84%28-9.68%
Mar 31, 2025135-3.57%111,187,22812.82%950.89%78-11.36%336.45%
Dec 31, 202433-67.96%21,547,862-71.71%220.35%19-71.64%8-52.94%
Sep 30, 202410311.96%76,172,3465.78%801.39%6724.07%17-
Jun 30, 20249221.05%72,012,804-0.19%760.99%54-6.90%1754.55%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds SMALLCAP World A8.40M7.48%1.75M
Polar Capital Biotech S Inc2.75M2.44%232.22K
Vanguard Health Care Inv2.16M1.92%-
Capital Group Global Equity Canada F1.32M1.17%-
Pictet-Biotech P USD975.89K0.87%11.95K
JPMorgan Small Cap Growth A827.03K0.73%-8.90K
Jennison Health Sciences Equity777.28K0.69%-501.37K
PGIM Jennison Health Sciences Z777.28K0.69%-
Jennison SMid Cap Core Equity734.72K0.65%19.25K
PGIM Jennison Small Company A734.72K0.65%2.10K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 15, 2025Topper James N-Buy$15.64K
Sep 09, 2025Kooij Louise Frederika Chief Accounting OfficerSell$1.34M
Sep 09, 2025Kooij Louise Frederika Chief Accounting OfficerSell$2.53M
Sep 08, 2025Topper James N-Buy$31.49K
Sep 03, 2025Kooij Louise Frederika Chief Accounting OfficerSell$453.45K

Insider Transactions Trends


DateBuySell
2025 Q3310
2025 Q235
2025 Q1217
2024 Q4126
2024 Q32-

NAMS Ownership FAQ


Who Owns NewAmsterdam Pharma?

NewAmsterdam Pharma shareholders are primarily institutional investors at 103.38%, followed by 0.39% insiders and -3.77% retail investors. The average institutional ownership in NewAmsterdam Pharma's industry, Biotech Stocks , is 306.59%, which NewAmsterdam Pharma falls below.

Who owns the most shares of NewAmsterdam Pharma?

NewAmsterdam Pharma’s largest shareholders are Frazier life sciences management (16.61M shares, 14.76%), Bain capital life sciences investors (10.72M shares, 9.53%), and Fcpm iii services b.v. (10.63M shares, 9.45%). Together, they hold 33.74% of NewAmsterdam Pharma’s total shares outstanding.

Does Blackrock own NewAmsterdam Pharma?

BlackRock is not among the top 10 institutional shareholders of NewAmsterdam Pharma.

Who is NewAmsterdam Pharma’s biggest shareholder by percentage of total assets invested?

Fcpm iii services b.v is NewAmsterdam Pharma’s biggest shareholder by percentage of total assets invested, with 52.16% of its assets in 10.63M NewAmsterdam Pharma shares, valued at 192.55M$.

Who is the top mutual fund holder of NewAmsterdam Pharma shares?

American Funds SMALLCAP World A is the top mutual fund holder of NewAmsterdam Pharma shares, with 7.48% of its total shares outstanding invested in 8.4M NewAmsterdam Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools